SIMULATIONS PLUS INC
Sector: Application Software
Latest Quote @ Wed Jun 6 15:34:38 (15 min delayed)
Last Day's Data
Simulations Plus, Inc., along its wholly owned subsidiary, engages in the design, development, and production of modeling and simulation software for pharmaceutical research, and education of pharmacy and medical students. It provides GastroPlus, a computer program for the simulation of the absorption and pharmacokinetics of drugs in the human gastrointestinal tract and laboratory animals; ADMET Predictor that provides estimates for properties of drug-like molecules; and ADMET Modeler to generate the predictive models used in ADMET Predictor. The company offers DDDPlus that simulates how different tablets and capsules disintegrate, and dissolve during IN VITRO dissolution experiments; and ChemTK program, which takes a set of molecular structures and one or more measured properties as input, and constructs classes or clusters of molecules. It also provides FutureLab, a science experiment simulation that incorporates the equations of chemistry and physics for each experiment, and allows middle school and high school students to design and conduct their own experiments in a virtual laboratory environment; augmentative and alternative communication and computer access software and devices for disabled persons; and Abbreviate!, a personal productivity software program for retail market. In addition, the company offers contract research services in gastrointestinal absorption, pharmacokinetics, structure-property model building, and related technologies areas of pharmaceutical industry. It markets its products through attendance and presentations at scientific meetings; exhibits at trade shows; seminars at pharmaceutical companies and government agencies; and through Internet, various communication media, employee representatives, and independent dealers and resellers in North and South America, Europe, Asia, and Oceania. The company was incorporated in 1996 and is headquartered in Lancaster, California.